首页> 外文期刊>The Keio Journal of Medicine >Perception of Thromboembolism Risk: Differences between the Departments of Internal Medicine and Emergency Medicine
【24h】

Perception of Thromboembolism Risk: Differences between the Departments of Internal Medicine and Emergency Medicine

机译:血栓栓塞风险的感知:内科和急诊科之间的差异

获取原文
获取外文期刊封面目录资料

摘要

The latest developments in emergency medicine (EM) have introduced new typologies of patients that have not been taken into account in previous studies of venous thromboembolism (VTE) risk. The aim of the current study was to evaluate by comparing the main international risk scores whether different perceptions of VTE risk exist in internal medicine (IM) departments and in EM departments. This cross-sectional observational study involved 23 IM and 10 EM departments of 21 different hospitals. The patient data were collected by physicians who were blinded to the purpose of the study. The data were analyzed using the main international risk scores. We analyzed 742 patients, 222 (30%) hospitalized in EM departments and the remaining 520 (70%) in IM departments. We found that fewer patients at risk for VTE were treated with low-molecular-weight heparin (LMWH) in EM departments than in IM departments. Moreover, there was significant statistical difference in the use of LMWH between IM and EM departments when the Padua score and immobilization criteria were used to assess the risk. The infrequent use of LMWH in EM patients may have several causes. For example, in EM departments, treatment of acute illness often takes higher priority than VTE risk evaluation. Moreover, immobilization criteria cannot be evaluated for all EM patients because of the intrinsic time requirements. For the aforementioned reasons, we believe that a different VTE risk score is required that takes into account the peculiarities of EM, and establishing such a score should be the object of future study.
机译:急诊医学(EM)的最新发展引入了新的患者类型,以前的静脉血栓栓塞(VTE)风险研究并未考虑这些类型。本研究的目的是通过比较主要的国际风险评分来评估内科(IM)部门和EM部门是否存在对VTE风险的不同认识。这项横断面观察研究涉及21家不同医院的23个IM和10 EM部门。患者数据由不了解研究目的的医生收集。使用主要的国际风险评分对数据进行了分析。我们分析了742名患者,其中EM部门住院222例(30%),IM部门剩余520例(70%)。我们发现,与IM部门相比,EM部门接受低分子量肝素(LMWH)治疗的发生VTE风险的患者更少。此外,当使用帕多瓦评分和固定标准评估风险时,IM和EM部门之间LMWH的使用存在显着的统计学差异。 EM患者不经常使用LMWH可能有多种原因。例如,在EM部门,对急性疾病的治疗通常比VTE风险评估具有更高的优先级。此外,由于内在的时间要求,无法针对所有EM患者评估固定标准。由于上述原因,我们认为需要考虑到EM的特殊性的不同的VTE风险评分,建立这样的评分应成为未来研究的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号